Measuring serum GDF15 levels, a noninvasive and simple-to-use test, could be potentially useful in evaluating the disease severity and prognosis of cirrhotic PBC patients, and it has its advantages over the existing prediction models. The gene discussed is GDF15; the disease is primary biliary cholangitis.